• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tat与人而非啮齿动物的P-TEFb复合物的特异性相互作用介导了HIV-1转录的物种特异性Tat激活。

Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription.

作者信息

Chen D, Fong Y, Zhou Q

机构信息

Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3206, USA.

出版信息

Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2728-33. doi: 10.1073/pnas.96.6.2728.

DOI:10.1073/pnas.96.6.2728
PMID:10077579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC15837/
Abstract

Tat stimulation of HIV-1 transcriptional elongation is species-specific and is believed to require a specific cellular cofactor present in many human and primate cells but not in nonpermissive rodent cells. Human P-TEFb, composed of Cdk9 and cyclin T1, is a general transcription elongation factor that phosphorylates the C-terminal domain of RNA polymerase II. Previous studies have also implicated P-TEFb as a Tat-specific cellular cofactor and, in particular, human cyclin T1 as responsible for the species-specific Tat activation. To obtain functional evidence in support of these hypotheses, we generated and examined the activities of human-rodent "hybrid" P-TEFb complexes. We found that P-TEFb complexes containing human cyclin T1 complexed with either human or rodent Cdk9 supported Tat transactivation and interacted with the Tat activation domain and the HIV-1 TAR RNA element to form TAR loop-dependent ribonucleoprotein complexes. Although a stable complex containing rodent cyclin T1 and human Cdk9 was capable of phosphorylating CTD and mediating basal HIV-1 elongation, it failed to interact with Tat and to mediate Tat transactivation, indicating that the abilities of P-TEFb to support basal elongation and Tat activation can be separated. Together, our data indicated that the specific interaction of human P-TEFb with Tat/TAR, mostly through cyclin T1, is crucial for P-TEFb to mediate a Tat-specific and species-restricted activation of HIV-1 transcription. Amino acid residues unique to human Cdk9 also contributed partially to the formation of the P-TEFb-Tat-TAR complex. Moreover, the cyclin box of cyclin T1 and its immediate flanking region are largely responsible for the specific P-TEFb-Tat interaction.

摘要

Tat对HIV-1转录延伸的刺激具有物种特异性,据信这需要许多人类和灵长类细胞中存在的一种特定细胞辅因子,而在非允许性啮齿动物细胞中则不存在。由Cdk9和细胞周期蛋白T1组成的人类P-TEFb是一种一般转录延伸因子,可使RNA聚合酶II的C末端结构域磷酸化。先前的研究也表明P-TEFb是一种Tat特异性细胞辅因子,特别是人类细胞周期蛋白T1负责物种特异性的Tat激活。为了获得支持这些假设的功能证据,我们生成并检测了人-啮齿动物“杂交”P-TEFb复合物的活性。我们发现,含有与人类或啮齿动物Cdk9复合的人类细胞周期蛋白T1的P-TEFb复合物支持Tat反式激活,并与Tat激活结构域和HIV-1 TAR RNA元件相互作用,形成依赖TAR环的核糖核蛋白复合物。虽然含有啮齿动物细胞周期蛋白T1和人类Cdk9的稳定复合物能够磷酸化CTD并介导基础HIV-1延伸,但它未能与Tat相互作用并介导Tat反式激活,这表明P-TEFb支持基础延伸和Tat激活的能力可以分开。总之,我们的数据表明,人类P-TEFb与Tat/TAR的特异性相互作用,主要通过细胞周期蛋白T1,对于P-TEFb介导HIV-1转录的Tat特异性和物种限制性激活至关重要。人类Cdk9特有的氨基酸残基也部分有助于P-TEFb-Tat-TAR复合物的形成。此外,细胞周期蛋白T1的细胞周期蛋白框及其紧邻的侧翼区域在很大程度上负责P-TEFb-Tat的特异性相互作用。

相似文献

1
Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription.Tat与人而非啮齿动物的P-TEFb复合物的特异性相互作用介导了HIV-1转录的物种特异性Tat激活。
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2728-33. doi: 10.1073/pnas.96.6.2728.
2
Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.在人免疫缺陷病毒1型启动子处组装多组分转录延伸复合物需要解除P-TEFb中的两种内在自抑制机制。
Mol Cell Biol. 2000 Aug;20(16):5897-907. doi: 10.1128/MCB.20.16.5897-5907.2000.
3
Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.人类和啮齿动物转录延伸因子P-TEFb:与1型人类免疫缺陷病毒tat及羧基末端结构域底物的相互作用
J Virol. 1999 Jul;73(7):5448-58. doi: 10.1128/JVI.73.7.5448-5458.1999.
4
Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.在产生负责P-TEFb介导的HIV-1转录的tat刺激的Cdk9/细胞周期蛋白T1异二聚体过程中对激酶特异性伴侣蛋白途径的需求。
J Biol Chem. 2000 Jan 7;275(1):279-87. doi: 10.1074/jbc.275.1.279.
5
CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.细胞周期蛋白依赖性激酶9(CDK9)的自磷酸化调节人类免疫缺陷病毒1型反式激活因子-P-TEFb复合物与反式激活应答元件(TAR)RNA的高亲和力结合。
Mol Cell Biol. 2000 Sep;20(18):6958-69. doi: 10.1128/MCB.20.18.6958-6969.2000.
6
Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.转录延伸因子P-TEFb在多个阶段介导Tat对HIV-1转录的激活作用。
EMBO J. 1998 Jul 1;17(13):3681-91. doi: 10.1093/emboj/17.13.3681.
7
Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.在1型人类免疫缺陷病毒转录过程中,Tat修饰CDK9的活性,使其对RNA聚合酶II羧基末端结构域的丝氨酸5进行磷酸化。
Mol Cell Biol. 2000 Jul;20(14):5077-86. doi: 10.1128/MCB.20.14.5077-5086.2000.
8
Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase.Tat激活1型人类免疫缺陷病毒转录延伸,且不依赖于TFIIH激酶。
Mol Cell Biol. 1999 Apr;19(4):2863-71. doi: 10.1128/MCB.19.4.2863.
9
Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.细胞周期蛋白T1/正性转录延伸因子b(P-TEFb)被招募至HIV-1长末端重复序列启动子近端RNA靶点,这对于转录的完全激活而言,既是必要的,也是充分的。
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7791-6. doi: 10.1073/pnas.96.14.7791.
10
MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.MAQ1和7SK RNA以转录依赖的方式与CDK9/细胞周期蛋白T复合物相互作用。
Mol Cell Biol. 2003 Jul;23(14):4859-69. doi: 10.1128/MCB.23.14.4859-4869.2003.

引用本文的文献

1
The HIV-1 Transcriptional Program: From Initiation to Elongation Control.HIV-1转录程序:从起始到延伸控制
J Mol Biol. 2025 Jan 1;437(1):168690. doi: 10.1016/j.jmb.2024.168690. Epub 2024 Jun 25.
2
Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer.Brd4 和 HEXIM1:在 P-TEFb 调节和癌症中的多种作用。
Biomed Res Int. 2014;2014:232870. doi: 10.1155/2014/232870. Epub 2014 Jan 29.
3
Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA.HIV Tat:P-TEFb 转录复合物组装和转移到 TAR RNA 过程中的转换步骤。
Mol Cell Biol. 2012 Dec;32(23):4780-93. doi: 10.1128/MCB.00206-12. Epub 2012 Sep 24.
4
Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.SWI/SNF染色质重塑复合物对HIV-1 Tat激活转录的影响。
Retrovirology. 2006 Aug 7;3:48. doi: 10.1186/1742-4690-3-48.
5
Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency.TFIIH募集到HIV长末端重复序列是HIV从潜伏期出现过程中的一个限速步骤。
EMBO J. 2006 Aug 9;25(15):3596-604. doi: 10.1038/sj.emboj.7601248. Epub 2006 Jul 27.
6
Arginine methylation regulates IL-2 gene expression: a role for protein arginine methyltransferase 5 (PRMT5).精氨酸甲基化调节白细胞介素-2基因表达:蛋白质精氨酸甲基转移酶5(PRMT5)的作用。
Biochem J. 2005 May 15;388(Pt 1):379-86. doi: 10.1042/BJ20040373.
7
Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.利用逆转录病毒复制系统筛选TAR RNA结合变色肽。
J Virol. 2004 Feb;78(3):1456-63. doi: 10.1128/jvi.78.3.1456-1463.2004.
8
Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.具有异源反式激活因子-反式激活应答元件相互作用的人类免疫缺陷病毒的复制
J Virol. 2003 Feb;77(3):1984-91. doi: 10.1128/jvi.77.3.1984-1991.2003.
9
Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF.Tat 的差异乙酰化作用协调其与共激活因子细胞周期蛋白 T1 和 PCAF 的相互作用。
EMBO J. 2002 Dec 16;21(24):6811-9. doi: 10.1093/emboj/cdf669.
10
HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim.HIV-1反式激活因子靶向微管以诱导细胞凋亡,这一过程由促凋亡的Bcl-2相关蛋白Bim所促进。
EMBO J. 2002 Dec 16;21(24):6801-10. doi: 10.1093/emboj/cdf683.

本文引用的文献

1
Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase.Tat激活1型人类免疫缺陷病毒转录延伸,且不依赖于TFIIH激酶。
Mol Cell Biol. 1999 Apr;19(4):2863-71. doi: 10.1128/MCB.19.4.2863.
2
The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor.HIV-1反式激活因子Tat的细胞共激活因子Tat-SF1是一种通用转录延伸因子。
Genes Dev. 1998 Oct 1;12(19):2992-6. doi: 10.1101/gad.12.19.2992.
3
Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.转录延伸因子P-TEFb在多个阶段介导Tat对HIV-1转录的激活作用。
EMBO J. 1998 Jul 1;17(13):3681-91. doi: 10.1093/emboj/17.13.3681.
4
Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation.酵母转录因子SPT5的人类同源物在HIV-1 Tat激活中的作用。
J Mol Biol. 1998 Mar 27;277(2):179-97. doi: 10.1006/jmbi.1997.1601.
5
Identification of multiple cyclin subunits of human P-TEFb.人P-TEFb多个细胞周期蛋白亚基的鉴定。
Genes Dev. 1998 Mar 1;12(5):755-62. doi: 10.1101/gad.12.5.755.
6
A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.一种新型的与CDK9相关的C型细胞周期蛋白直接与HIV-1反式激活因子(Tat)相互作用,并介导其与TAR RNA的高亲和力、环特异性结合。
Cell. 1998 Feb 20;92(4):451-62. doi: 10.1016/s0092-8674(00)80939-3.
7
DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs.DSIF是一种调节RNA聚合酶II持续合成能力的新型转录延伸因子,由人Spt4和Spt5同源物组成。
Genes Dev. 1998 Feb 1;12(3):343-56. doi: 10.1101/gad.12.3.343.
8
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro.P-TEFb激酶在体内和体外对于HIV Tat转录激活都是必需的。
Genes Dev. 1997 Oct 15;11(20):2633-44. doi: 10.1101/gad.11.20.2633.
9
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.转录延伸因子P-TEFb是HIV-1反式激活因子tat在体外反式激活所必需的。
Genes Dev. 1997 Oct 15;11(20):2622-32. doi: 10.1101/gad.11.20.2622.
10
Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase.一种新型羧基末端结构域激酶对RNA聚合酶II延伸潜能的调控
J Biol Chem. 1996 Oct 25;271(43):27176-83. doi: 10.1074/jbc.271.43.27176.